Effect of estrogens on IL-1β promoter activity

Journal of Steroid Biochemistry and Molecular Biology

Volumn 66, Issue 4, 1998, Pages 203-210

  Ruh, Mary F ^a   Bi, Yanhua ^a   D'Alonzo, R ^a   Bellone, Clifford J ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; INTERLEUKIN 1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; ESTROGEN ACTIVITY; GENE EXPRESSION REGULATION; HEART DISEASE; HUMAN; HUMAN CELL; NONHUMAN; OSTEOPOROSIS; PATHOGENESIS; TRANSCRIPTION REGULATION;

NON-PROGRAMMATIC;

ANIMALS; CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DRUG SYNERGISM; ESTRADIOL; ESTROGEN ANTAGONISTS; EXONS; GENES, REPORTER; HUMANS; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; PROGESTERONE; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; TAMOXIFEN; TESTOSTERONE; TRANSCRIPTION, GENETIC; TRANSFECTION;

ANIMALIA;

EID: 0031668090     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(98)00042-9     Document Type: Article

References (49)

1. Knudsen P. J., Dinarello C. A. and Strom T. B., Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin-1 in U937 cells. J. Immunol. 139 (1987) 4129-4134.
2. Beutler B., Krochin N., Milsark I. W., Luedke C. and Cerami A., Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 232 (1986) 977-980.
3. Cupps T. R. and Fauci A. S., Corticosteroid-mediated immunoregulation in man. [Review]. Immunological Reviews 65 (1982) 133-155.
4. Pacifici R., Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. [Review]. J. Bone Miner. Res. 11 (1996) 1043-1051.
5. Ettinger B., Genant H. K. and Cann C. E., Long-term estrogen replacement therapy prevents bone loss and fractures. Ann. Int. Med. 102 (1985) 319-324.
6. Christiansen C., Christensen M. S., Jensen J., McNair P., Hagen C., Stocklund K. E. and Transbol I., Prevention of early post-menopausal bone mineral loss. Controlled 2-year study of 315 women. Ugeskrift for Laeger 142 (1980) 2896-2901.
7. Frazier-Jessen M. R. and Kovacs E. J., Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages. J. Immunol. 154 (1995) 1838-1845.
8. Ray A., Prefontaine K. E. and Ray P., Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J. Biol. Chem. 269 (1994) 12940-12946.
9. Pottratz S. T., Bellido T., Mocharla H., Crabb D. and Manolagas S. C., 17 beta-estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J. Clin. Invest. 93 (1994) 944-950.
10. Stein B. and Yang M. X., Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol. Cell. Biol. 15 (1995) 4971-4979.
11. Li Z. G., Danis V. A. and Brooks P. M., Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. Clin. Exp. Rheum. 11 (1993) 157-162.
12. Pivirotto L. A., Cissel D. S. and Keeting P. E., Sex hormones mediate interleukin-1 beta production by human osteoblastic HOBIT cells. Mol. Cell. Endocrin. 111 (1995) 67-74.
13. Fox H. S., Bond B. L. and Parslow T. G., Estrogen regulates the IFN-gamma promoter. J. Immunol. 146 (1991) 4362-4367.
14. Auron P. E. and Webb A. C., Molecular biology of interleukin-1. Lymphokines 14 (1987) 33-61.
15. Dinarello C. A., Interleukin-1 and interleukin-1 antagonism. Blood 77 (1991) 1627-1652.
16. Muegge K. and Durum S., Cytokines and transcription factors. [Review]. Cytokine 2 (1990) 1-8.
17. Dinarello C., Interleukin-1. Review of Infectious Disease 6 (1984) 51-96.
18. Firestein G. S. and Zvaifler N. J., Immunopathogenesis of rheumatoid arthritis. Immunology Series 54 (1991) 141-161.
19. Firestein G. S., The immunopathogenesis of rheumatoid arthritis. Current Opinion in Rheumatology 3 (1991) 398-406.
20. Arend W. P. and Dayer J. M., Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis and Rheum. 33 (1990) 305-315.
21. Hess E. V., Cytokine inhibitors and osteoarthritis. J. Rheumatology 17 (1990) 1123-1124.
22. Lopes-Virella M. F. and Virella G., Immune mechanisms in the pathogenesis of atherosclerosis. Adv. Exp. Med. and Biol. 285 (1991) 393-392.
23. Hansson G. K., Immune and inflammatory mechanisms in the development of atherosclerosis. Br. Heart J. 69 (1993) S38-S41.
24. Godambe S. A., Chaplin D. D. and Bellone C. J., Regulation of IL-1α and IL-1β expression in murine macrophages by lipopolysaccharide. Cytokine 5 (1993) 327-335.
25. Godambe S. A., Chaplin D. D., Takova T. and Bellone C. J., An upstream NFIL-6 like site located within a DNase I hypersensitivity region mediates LPS-induced transcription of the murine interleukin-1β gene. J. Immunol. 153 (1994) 143-152.
26. Godambe S. A., Chaplin D. D., Takova T. and Bellone C. J., A novel enhancer mediates LPS-induced transcription of the murine IL-1β gene. Mol. Cell. Biol. 15 (1995) 112-119.
27. Godambe S. A., Chaplin D. D., Takova T. and Bellone C. J., An NFIL-6 like sequence near the transcriptional initiation start site is necessary for the LPS induction of murine interleukin-1B. DNA and Cell Biol. 13 (1994) 561-569.
28. Godambe S. A., Chaplin D. D., Takova T. and Bellone C. J., Molecular dissection of the murine IL-1β promoter. American Journal of Therapeutics 2 (1995) 1-10.
29. Koren H. S., Handwereger B. S. and Wunderlich J. R., Identification of macrophage-like characteristics in a cultured murine tumor line. J. Immunol. 114 (1975) 894-897.
30. Kushner P. J., Hort E., Shine J., Baxter J. D. and Greene G. L., Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens. Molecular Endocrin. 4 (1990) 1465-1473.
31. Tora L., Mullick A., Metzger D., Ponglikitmongkol M., Park I. and Chambon P., The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. EMBO J. 8 (1989) 1981-1986.
32. Chen L. and Okayama H., Calcium phosphate-mediated gene transfer: a highly efficient system for stably transforming cells with plasmid DNA. Biotechniques 6 (1988) 632-638.
33. Seed B. and Sheen J. Y., A simple phase-extraction assay for chloramphenicol acyltransferase activity. Gene 67 (1988) 271-277.
34. Chirgwin J. M., Przybyla A. E., MacDonald R. J. and Rutter W. J., Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18 (1979) 5294-5299.
35. Zhu H., Macreadie I. G. and Butow R. A., RNA processing and expression of an intron-encoded protein in yeast mitochondria: role of a conserved dodecamer sequence. Mol. Cell. Biol. 7 (1987) 2530-2537.
36. Ruh T. S., Baudendistel L. J., Nicholson W. F. and Ruh M. F., The effects of antioestrogens on the oestrogen receptor. Journal of Steroid Biochemistry 11 (1979) 315-322.
37. 3H]H1285 with the cytoplasmic oestrogen receptor. Biochem. J. 217 (1984) 819-826.
38. Gulshan S., McCruden A. B. and Stimson W. H., Oestrogen receptors in macrophages. Scand. J. Immunol. 31 (1990) 691-697.
39. Hu S. K., Mitcho Y. L. and Rath N. C., Effect of estradiol on interleukin 1 synthesis by macrophages. International Journal of Immunopharmacology 10 (1988) 247-252.
40. Weusten J. J., Blankenstein M. A., Gmelig-Meyling F. H., Schuurman H. J., Kater L. and Thijssen J. H., Presence of oestrogen receptors in human blood mononuclear cells and thymocytes. Acta Endocrinologica 112 (1986) 409-414.
41. Yamamoto K. R., Steroid receptor regulated transcription of specific genes and gene networks. Annual Review of Genetics 19 (1985) 209-252.
42. Ansar Ahmed S., Penhale W. J. and Talal N., Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. [Review]. Amer. J. Path. 121 (1985) 531-551.
43. Grossman C. J., Interactions between the gonadal steroids and the immune system. Science 227 (1985) 257-261.
44. Talal N. (ed.), Proceedings of the Kroc Foundation Conference on Sex Factors. Steroid hormones and the host response. Arthritis and Rheum. 36 (1979) 1162-1198.
45. Yang N. N., Venugopalan M., Hardikar S. and Glasebrook A., Identification of an estrogen response element activated by metabolites of 17β-estradoil and raloxifene. Science 273 (1996) 1222-1225.
46. Gray J. G., Chandra G., Clay W. C., Stinnet S. W., Hanneline S. A., Lorenz J. J., Patel I. R., Wisely G., Purdon P. J., Taylor D. and Kost T. A., A CRE/ATF-like site in the upstream regulatory sequence of the human interleukin-1β gene is necessary for induction of U937 and THP-1 monocyte cell lines. Mol. Cell. Biol. 13 (1993) 6678-6689.
47. Hiscott J., Marois J., Garoutalis J., D'Addario M., Reulston A., Kwan I., Pepin N., Lacoste J. N., Nguyen H., Bensi G. and Fenton M., Characterization of a functional NF-kB site in the human interleukin-1β promoter: evidence for a positive autoregulatory loop. Mol. Cell. Biol. 13 (1993) 6231-6240.
48. Kominato Y., Galson D., Waterman W. R., Webb A. C. and Auron P. E., Monocyte expression of the human prointerleukin 1β gene (IL1B) is dependent on promoter sequences which bind the hematopoietic transcription factor Spi-1/PU.1. Mol. Cell. Biol. 15 (1995) 59-68.
49. Zhang Y. and Rom W. N., Regulation of the interleukin 1β (IL-1b) gene by mycobacterial components and lipopolysaccharide is mediated by two nuclear factor-IL6 motiff. Mol. Cell. Biol. 13 (1993) 3831-3837.